Buongiorno from the @fibrotarget.bsky.social General Assembly meeting in Milan!
It’s been an exciting start to the meeting we’ve already covered advancements in #fibrosis biomarker characterisation, imaging and how to quantify this and began laying the foundation for an upcoming clinical trial!
Motilent
FIBROTARGET GAM: Day 1 at Humanitas University in Milan
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
